Table 3 Comparison of survival in different groups of patients
Items | Patients with Resections (N = 42) | Patients with Radiotherapy (N = 79) | Patients with combination of resections and radiotherapy (N = 6) | p for survival |
|---|---|---|---|---|
2-year no local recurrence survival rate [±SD] | 81.0% [±7.1%] | 92.8% [±3.1%] | 66.7%[±36.7%] | 0.652 |
Local relapse of nodules without new lesions | 2/42 (4.8%) | 1/79 (1.3%) | 1/6 (16.7%) | N/Aa |
Local relapse of nodules with new lesions | 6/42 (14.3%) | 10/79 (12.7%) | 1/6 (16.7%) | N/Aa |
Progression without local relapse | 19/42 (45.2%) | 49/79 (62.0%) | 3/6 (50.0%) | |
Events for progression in total | 27/42 (64.3%) | 60/79 (75.9%) | 5/6 (83.3%) | |
From resections/radiotherapy to any event (median, Q1, Q3) months | 10.0 (4.1, 17.1) | 10.1 (5.8, 14.5) | N/A | 0.755 |
From resections/radiotherapy to death (mean, 95%CI)b months | 37.6 (32.5, 42.7) | 67.0 (58.7, 75.3) | 21.5 (17.3, 25.7) | 0.712 |